Ra Capital Management, L.P. G1 Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $11 Million - $19.6 Million	-483,990 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $1.94 Million - $3.76 Million	120,939 Added 33.31%	483,990 $14.8 Million
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $5.23 Million - $7.79 Million	363,051 New	363,051 $6.03 Million
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $1.73 Million - $2.72 Million	-40,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$19.05 - $41.76 $2.28 Million - $5 Million	-119,780 Reduced 74.97%	40,000 $1.48 Million
Q4 2017 Feb 14, 2018	SELL	$19.01 - $26.2 $48 Million - $66.1 Million	-2,524,464 Reduced 94.05%	159,780 $3.17 Million
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $33.6 Million - $72.8 Million	2,684,244	2,684,244 $49.8 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.